Recruiting Fabry Disease Studies in Phoenix
About Fabry Disease Clinical Trials in Phoenix
Fabry disease is a rare genetic disorder caused by deficiency of the enzyme alpha-galactosidase A, leading to accumulation of a fatty substance in cells. It can affect the heart, kidneys, and nervous system. Treatment includes enzyme replacement therapy and chaperone therapy.
There are currently 2 fabry disease clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 9,022 participants. Research is being sponsored by Genzyme, a Sanofi Company, Chiesi Farmaceutici S.p.A.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fabry Disease Clinical Trials in Phoenix — FAQ
Are there fabry disease clinical trials in Phoenix?
Yes, there are 2 fabry disease clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Phoenix?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.
Are clinical trials in Phoenix free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.
What fabry disease treatments are being tested?
The 2 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for fabry disease.
Data updated August 28, 2026 from ClinicalTrials.gov